GleamWall
中文EN

RCEL AVITA Medical, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1762303 · Fiscal year ends 12/31

Financial factors as of 2025-09-30 (2025Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY20.6%
TTM net income YoY15.3%
TTM EPS YoY18.8%
Revenue 3-yr CAGR31.4%
Net income 3-yr CAGR—

Margins

Gross margin83.7%
Operating margin-58.1%
Net margin-67.1%
FCF margin-51.3%
EBITDA margin-55.7%

Returns

ROE-1,746.3%
ROA-67.1%
ROIC (approx.)-117.7%
Asset turnover1.00x

Leverage & solvency

Liabilities / assets110.5%
Debt / equity—
Current ratio0.67x
Interest coverage-8.33x

Cash quality & payout

Operating cash flow / net income0.70x
Accruals ratio-20.3%
Payout ratio—
Capex / revenue4.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$26.11M$21.70M$19.25M$17.61M$17.06M$18.42M$18.51M$18.41M
Cost of revenue$4.17M$3.94M$3.52M$3.30M$3.19M$3.47M$2.83M$2.28M
Gross profit$21.94M$17.77M$15.73M$14.31M$13.88M$14.95M$15.68M$16.13M
R&D expense$4.70M$5.08M$5.63M$5.69M$3.75M$5.12M$6.28M$4.85M
SG&A expense$6.31M$5.97M$6.06M$7.09M$7.23M$6.67M$6.39M$7.12M
Operating income-$2.63M-$6.86M-$8.80M-$10.41M-$9.15M-$11.15M-$11.83M-$9.96M
Interest expense$1.48M$1.46M$1.42M$1.25M$1.27M$1.25M$1.23M$1.30M
Pretax income-$6.16M-$7.63M-$10.62M-$11.64M-$13.17M-$9.92M-$13.85M-$11.57M
Income tax$65,000$33,000-$11,000-$17,000$15,000$4,000$8,000$19,000
Net income-$6.22M-$7.66M-$10.61M-$11.62M-$13.19M-$9.92M-$13.86M-$11.59M
EBITDA-$2.26M-$6.47M-$8.18M-$9.71M-$8.73M-$10.75M-$11.31M-$9.55M
EPS (basic)-0.20-0.25-0.35—-0.46-0.38-0.53—
EPS (diluted)-0.20-0.25-0.35—-0.46-0.38-0.53—
Weighted avg. shares (diluted)30.87M30.75M30.54M—28.39M26.37M26.25M—
Banking
Provision for credit losses$22,000$14,000$0$7,000-$11,000$1,000-$7,000-$10,000
Balance sheet
Cash & equivalents$10.50M$9.14M$8.31M$10.24M$15.42M$12.22M$14.87M$14.05M
Short-term investments$0$2.00M$5.95M$7.94M$7.89M$3.47M$10.95M$21.84M
Receivables$10.34M$9.87M$9.88M$9.09M$9.01M$11.34M$9.10M$11.80M
Inventory$4.80M$5.29M$6.12M$6.93M$7.24M$7.54M$8.39M$7.27M
Current assets$27.68M$28.39M$31.65M$35.49M$41.37M$36.25M$47.97M$57.00M
PP&E, net$7.36M$7.68M$8.21M$8.63M$9.88M$9.69M$9.89M$10.02M
Intangibles$5.55M$5.25M$5.44M$5.64M$5.20M$5.31M$5.45M$5.57M
Total assets$46.79M$47.78M$51.54M$56.39M$63.73M$58.13M$69.56M$79.71M
Current liabilities$23.04M$68.71M$66.67M$62.68M$61.83M$62.60M$22.96M$20.16M
Short-term debt$0$46.66M$46.14M$42.98M$42.45M——$0
Long-term debt$45.48M——$0$0$42.22M$41.46M$42.24M
Total debt$45.48M——$42.98M$42.45M$42.22M$41.46M$42.24M
Total liabilities$77.83M$75.61M$74.71M$73.04M$70.39M$70.98M$74.06M$74.97M
Shareholders' equity-$31.04M-$27.84M-$23.17M-$16.65M-$6.67M-$12.89M-$4.57M$4.50M
Net debt$34.98M——$32.74M$27.03M$30.00M$26.59M$28.20M
Shares outstanding30.96M30.93M30.78M30.57M30.49M26.61M26.43M26.35M
Cash flow statement
Operating cash flow-$710,000-$3.50M-$10.07M-$5.44M-$5.22M-$10.23M-$10.31M-$8.08M
Capital expenditure$111,000$108,000$19,000-$674,000$934,000$524,000$221,000$1.61M
Free cash flow-$821,000-$3.60M-$10.09M-$4.76M-$6.15M-$10.75M-$10.53M-$9.69M
Investing cash flow$1.89M$3.89M$2.04M$11,000-$5.34M$7.02M$10.77M$2.47M
Financing cash flow$182,000$437,000$6.10M$248,000$13.77M$559,000$363,000$1.02M
Depreciation & amortization$365,000$385,000$627,000$700,000$421,000$400,000$521,000$409,000
Stock-based compensation$1.67M$1.99M$1.10M$1.37M$2.78M$2.67M$2.69M$2.80M

Free plan shows the latest 8 periods; Pro shows all 33 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.